Biotech News

Bepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for chronic hepatitis B

GSK plc (GSK)gsk.com2026-05-28 16:42 ESTCompany update

Pivotal B-Well data show a significant 19% functional cure in the overall study population and 26% in patients with lower viral activity.

Open original release

Related news

No closely related headlines were available from the latest feed snapshot.

View all latest news

GSK plc

GSK plc is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

GSKGSK plc2026-06-12 02:09:41 EST

GSK’s momelotinib granted Orphan Drug Designations in the US and EU for VEXAS syndrome

GSKGSK plc2026-06-09 02:03:19 EST

GSK enters agreement to acquire Nuvalent, Inc.

GSKGSK plc2026-05-26 17:15:19 EST

GSK to showcase long-term outcomes and pipeline expansion with latest oncology research at ASCO and EHA

GSKGSK plc2026-05-18 10:09:39 EST

GSK’s RSV vaccine, Arexvy, receives expanded approval in Japan for adults aged 18–59 at increased risk

Stock data

Close: —
Market cap: —
Exchange: NYSE
Sector: Biotechnology
Location: United States